CM101
CM101 is an anti-pathoangiogenic polysaccharide that can be derived from group B streptococcus. CM101 can inhibit inflammatory angiogenesis and accelerate wound healing in mouse models as well as minimizing scarring after spinal cord injury. CM101 also causes rapid tumor neovascularitis, infiltration of inflammatory cells, inhibition of tumor growth and tumor apoptosis[1][2].
Product Specifications
CAS Number
[2244739-55-5]
UNSPSC
12352203
Target
Apoptosis
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer; Cardiovascular Disease
References & Citations
[1]Nanney, L. B., et al., (2001) . CM101 stimulates cutaneous wound healing through an anti-angiogenic mechanism. Angiogenesis, 4 (1), 61–70. |[2]Yan, H. P., et al., (1998) . Functional studies on the anti-pathoangiogenic properties of CM101. Angiogenesis, 2 (3), 219–233.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1164856-01 0.02 mg (E-Coli)
Recombinant Caldivirga maquilingensis DNA-directed RNA polymerase subunit N (rpoN)
Ask
View Details 
MBS1164856-02 0.1 mg (E-Coli)
Recombinant Caldivirga maquilingensis DNA-directed RNA polymerase subunit N (rpoN)
Ask
View Details MBS1164856-03 0.02 mg (Yeast)
Recombinant Caldivirga maquilingensis DNA-directed RNA polymerase subunit N (rpoN)
Ask
View Details MBS1164856-04 0.1 mg (Yeast)
Recombinant Caldivirga maquilingensis DNA-directed RNA polymerase subunit N (rpoN)
Ask
View Details MBS1164856-05 0.02 mg (Baculovirus)
Recombinant Caldivirga maquilingensis DNA-directed RNA polymerase subunit N (rpoN)
Ask
View Details 
MBS1164856-06 1 mg (E-Coli)
Recombinant Caldivirga maquilingensis DNA-directed RNA polymerase subunit N (rpoN)
Ask
View Details